The relation of COX-2 expression with other prognostic parameters in invasive ductal carcinomas

被引：0
|
作者：
Barisik, Nagehan Oezdemir
Keser, Sevinc
Guel, Aylin
Cayirci, Mine
Karadayi, Nimet
Guemues, Mahmut
Eser, Mehmet
机构：
来源：
VIRCHOWS ARCHIV | 2008年 / 452卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：S146 / S147
页数：2
相关论文
共 50 条
  • [21] PROGNOSTIC SIGNIFICANCE OF MORPHOMETRIC PARAMETERS OF NUCLEOLI AND NUCLEI OF INVASIVE DUCTAL BREAST CARCINOMAS
    Karpinska-Kaczmarczyk, Katarzyna
    Kram, Andrzej
    Kaczmarczyk, Mariusz
    Domagala, Wenancjusz
    POLISH JOURNAL OF PATHOLOGY, 2009, 60 (03) : 124 - 129
  • [22] Expression of COX-2 and prognostic outcome in uveal melanoma
    Cryan, Lorna M.
    Paraoan, Luminita
    Hiscott, Paul
    Damato, Bertil E.
    Grierson, Ian
    Gray, Donna
    Farrell, Michael
    Doherty, Glen A.
    Fitzgerald, Desmond J.
    O'Brien, Colm
    CURRENT EYE RESEARCH, 2008, 33 (02) : 177 - 184
  • [23] PROGNOSTIC VALUE OF COX-2 EXPRESSION FOR COLORECTAL CANCER
    Vargas, Caroline T.
    Natividade, Leonardo F.
    Arruda, Polliane
    Netto, Mario R. Montemor
    GASTROENTEROLOGY, 2018, 154 (06) : S351 - S351
  • [24] Cox-2 overexpression in triple-negative invasive ductal breast cancer with correlation to clinicopathological parameters and neoangiogenesis
    Volos, L.
    Dudash, A.
    BREAST, 2023, 68 : S35 - S36
  • [25] Expression of inflammatory modulator COX-2 in pancreatic ductal adenocarcinoma and its relationship to pathologic and clinical parameters
    Merati, K
    Siadaty, MS
    Andea, A
    Sarkar, F
    Ben-Josef, E
    Mohammad, R
    Philip, P
    Shields, AF
    Vaitkevicius, V
    Grignon, DJ
    Adsay, NV
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2001, 24 (05): : 447 - 452
  • [26] Prognostic impact of syndecan-1 expression in invasive ductal breast carcinomas
    Loussouarn, D.
    Campion, L.
    Sagan, C.
    Frenel, J-S
    Dravet, F.
    Classe, J-M
    Pioud-Martigny, R.
    Berton-Rigaud, D.
    Bourbouloux, E.
    Mosnier, J-F
    Bataille, F-R
    Campone, M.
    BRITISH JOURNAL OF CANCER, 2008, 98 (12) : 1993 - 1998
  • [27] Prognostic impact of syndecan-1 expression in invasive ductal breast carcinomas
    D Loussouarn
    L Campion
    C Sagan
    J-S Frenel
    F Dravet
    J-M Classe
    R Pioud-Martigny
    D Berton-Rigaud
    E Bourbouloux
    J-F Mosnier
    F-R Bataille
    M Campone
    British Journal of Cancer, 2008, 98 : 1993 - 1998
  • [28] COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ
    Boland, GP
    Butt, IS
    Prasad, R
    Knox, WF
    Bundred, NJ
    BRITISH JOURNAL OF CANCER, 2004, 90 (02) : 423 - 429
  • [29] COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ
    G P Boland
    I S Butt
    R Prasad
    W F Knox
    N J Bundred
    British Journal of Cancer, 2004, 90 : 423 - 429
  • [30] Surviving is related to COX-2 expression and recurrence in ductal carcinoma in situ
    Barnes, NLP
    Haywood, PB
    Flint, PJ
    Knox, WF
    Bundred, NJ
    BRITISH JOURNAL OF SURGERY, 2005, 92 : 31 - 31
12345